基于可变形盆腔模体的前列腺MRI引导自适应放疗剂量累积端到端实证验证
本研究利用可变形盆腔模体模拟六次MR引导前列腺SBRT疗程,以胶片测量为参考验证两种可变形图像配准(DIR)方法的剂量累积精度。基于轮廓的形变(CB-D)在直肠和膀胱表面的平均剂量偏差分别为0.6%和0.3%,几何精度也显著优于基于强度的形变(IB-D),后者在直肠和膀胱的剂量累积不准确度分别为7.2%和2.5%。
要点
- CB-D法直肠和膀胱表面剂量偏差仅0.6%和0.3%,与胶片测量高度一致。
- IB-D法剂量累积不准确度较高,直肠达7.2%、膀胱达2.5%。
- CB-D几何精度显著优于IB-D,表现为DSC更高、RDE和HDD更低。
核心结论
- 采用基于轮廓的DIR方法时,MR引导前列腺SBRT的剂量累积与参考胶片测量取得了良好一致性。
研究设计与样本
- 使用可变形盆腔模体模拟六次MR引导前列腺SBRT疗程,膀胱和直肠的OAR信息来源于实际患者数据。
- 以OAR表面的GafChromic EBT3胶片条(1.25×2.0 cm²)测量值为参考,验证两种DIR方法的剂量累积精度。
主要发现
- CB-D法在直肠和膀胱表面的平均剂量偏差分别为0.6%和0.3%。
- IB-D法整体平均剂量累积不准确度在直肠为7.2%、膀胱为2.5%。
- CB-D法的DSC值显著高于IB-D,RDE和HDD偏差显著低于IB-D。
关键数值与推荐
- 剂量学精度通过量化剂量差异及gamma-index分析评估。
- 几何精度通过DSC、HDD及所有标记点的RDE评估。
临床怎么用
- MR引导前列腺SBRT中宜优先选用基于轮廓的DIR方法进行OAR剂量累积。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This work evaluates the accuracy of deformable dose accumulation for organs at risk (OAR) in MR-guided prostate SBRT using an anthropomorphic deformable phantom. MATERIALS AND METHODS: Six MR-guided prostate SBRT treatment courses were simulated using volumetric OAR (bladder and rectum) information derived from actual patient data. Deformed OAR contours, geometrical landmarks and GafChromic EBT3 film strips (1.25 × 2.0 cm2) placed at the surface of the OARs were used to validate DIR-based dose accumulation in MRgRT. Two DIR methods were applied: an intensity-based deformation (IB-D) applied to the whole image, and a contour-based deformation (CB-D), resulting in a separate deformation and dose accumulation for each OAR. Dosimetric accuracy was evaluated by quantifying the dose differences, and performing a gamma-index analysis between measured and DIR-derived accumulated dose for both OARs. Geometrical accuracy was assessed by measuring the Dice similarity coefficient (DSC), Hausdorff distance (HDD) and residual distance error (RDE) for all markers at each fraction. RESULTS: CB-D resulted in an average dose deviation from film measurements for rectum and bladder surfaces of 0.6% and 0.3%, respectively. IB-D led to worse results resulting in an overall average dose accumulation inaccuracy of 7.2% and 2.5% for rectum and bladder. CB-D also showed a higher geometrical accuracy than IB-D with significantly higher DSC values and lower RDE and HDD deviations. CONCLUSION: Empirical validation of dose accumulation in MR-guided SBRT for prostate cancer obtained a good agreement with reference film measurements when using a contour-based DIR approach.
引用
- Bohoudi O, Lagerwaard FJ, Bruynzeel AME, et al. End-to-end empirical validation of dose accumulation in MRI-guided adaptive radiotherapy for prostate cancer using an anthropomorphic deformable pelvis phantom. Radiother Oncol. 2019. PMID: 31585817. doi:10.1016/j.radonc.2019.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。